Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapy.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001414:Bacitracin / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy / Q000209:etiology; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003231:Conjunctivitis / Q000188:drug therapy / Q000209:etiology*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005141:Eyelid Diseases / Q000209:etiology*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000209:etiology*; D011550:Pseudomonas aeruginosa
D000970:Antineoplastic Agents; D005839:Gentamicins; D011113:Polymyxins; D001414:Bacitracin; D003520:Cyclophosphamide; D002228:Carbenicillin; D009355:Neomycin; D002512:Cephalothin; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate